XML 51 R33.htm IDEA: XBRL DOCUMENT v3.25.0.1
Disaggregated Revenues (Tables)
 12 Months Ended
Dec. 31, 2024
Disaggregation of Revenue [Abstract]  
Summary of Disaggregation of Revenue by Nature
The following table provides information regarding total revenues (dollars in thousands):
 Year Ended December 31,
 202420232022
Net product sales   
Qelbree$241,273 $140,192 $61,322 
GOCOVRI130,824 119,637 104,421 
Oxtellar XR99,464 113,404 115,345 
APOKYN73,926 75,083 75,305 
Trokendi XR63,201 94,336 261,221 
Other(1)
29,008 31,281 31,818 
Total net product sales637,696 573,933 649,432 
Royalty, licensing and other revenues24,121 33,588 17,806 
Total revenues$661,817 $607,521 $667,238 
______________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.
The following table shows the percentage of net product sales to total net product sales:
Percentage of Net Product Sales
Year Ended December 31,
202420232022
Qelbree38%24%9%
GOCOVRI20%21%16%
Oxtellar XR16%20%18%
APOKYN12%13%12%
Trokendi XR10%16%40%
Other(1)
4%6%5%
Total100%100%100%
______________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.